Cephalon, North American Vaccine, Abbott deal

NVX will acquire CEPH's Beltsville pharmaceutical manufacturing facility for $25 million, to be paid in

Read the full 152 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE